Blythe Sather, Ph.D.
Vice President, Head of Research | Tune Therapeutics
Professional Overview
Blythe Sather, Ph.D., is an accomplished research executive with over 15 years of experience in the biopharmaceutical industry. As the Vice President and Head of Research at Tune Therapeutics, she leads a talented team of scientists focused on developing innovative cell therapies to address complex medical challenges.
Current Role
In her current role, Dr. Sather is responsible for overseeing all aspects of the research and development pipeline at Tune Therapeutics. She collaborates closely with cross-functional teams to drive the company's strategic research initiatives, with a particular emphasis on T-cell engineering and immunotherapies. Under her leadership, the research team has made significant strides in advancing novel cell-based treatments, resulting in several promising candidates entering clinical development.
Career Progression
Prior to joining Tune Therapeutics, Dr. Sather held senior research positions at Lyell Immunopharma and Juno Therapeutics, where she made substantial contributions to the advancement of cell therapy technologies. As the Senior Director of T-cell engineering at Lyell Immunopharma, she led a team of scientists in developing innovative approaches to enhance the potency and persistence of engineered T cells. Earlier in her career, she held roles as an Associate Director and Senior Research Scientist at Juno Therapeutics, where she played a crucial role in the development of their lead CAR-T product candidates.
Academic Background
Dr. Sather holds a Ph.D. in Immunology from the University of Washington, where she conducted groundbreaking research on the regulation of T-cell responses under the mentorship of Dr. Daniel Campbell. Her academic achievements include several peer-reviewed publications and presentations at leading scientific conferences.
Areas of Expertise
- T-cell engineering and immunotherapy
- Preclinical research and development
- Innovative cell therapy technologies
- Cross-functional team leadership and collaboration
- Strategic planning and program management
Professional Impact
Throughout her career, Dr. Sather has made significant contributions to the field of cell therapy research. Her work has led to the advancement of multiple novel cell-based treatments, several of which have progressed to clinical trials. She is recognized as a thought leader in the industry and has been invited to speak at prestigious scientific meetings, sharing her expertise and insights with her peers.
Conclusion
With her extensive knowledge, proven leadership skills, and commitment to driving innovation, Dr. Blythe Sather is well-positioned to continue making a meaningful impact in the field of cell therapy research. As the Vice President and Head of Research at Tune Therapeutics, she is dedicated to exploring new frontiers in this rapidly evolving field and delivering transformative treatments to patients in need.
